Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:computer
|
| gptkbp:advocates_for |
gptkb:Educational_Institution
gptkb:municipality awareness campaigns parent education healthcare provider training |
| gptkbp:affects |
gptkb:Person
|
| gptkbp:age |
children and teenagers
|
| gptkbp:associated_with |
aspirin use
|
| gptkbp:caused_by |
gptkb:healthcare_organization
|
| gptkbp:clinical_trial |
ongoing research
|
| gptkbp:complications |
gptkb:cemetery
permanent brain damage |
| gptkbp:current_use |
acute liver failure
encephalopathy |
| gptkbp:first_described_by |
gptkb:1963
|
| gptkbp:gender |
more common in males
|
| gptkbp:healthcare |
avoid aspirin in viral infections
|
| gptkbp:historical_event |
increased incidence linked to aspirin
notable cases in the 1980s |
| gptkbp:historical_significance |
public health awareness
|
| https://www.w3.org/2000/01/rdf-schema#label |
Reye's syndrome
|
| gptkbp:is_protected_by |
avoiding aspirin in children
|
| gptkbp:research_focus |
treatment options
pathophysiology |
| gptkbp:risk_factor |
viral illnesses
taking aspirin |
| gptkbp:social_responsibility |
rare
clinical evaluation metabolic acidosis varies by severity hypoglycemia elevated liver enzymes elevated ammonia levels |
| gptkbp:symptoms |
vomiting
confusion seizures irritability hypoglycemia lethargy liver dysfunction coma agitation fatty liver brain swelling hyperventilation |
| gptkbp:treatment |
intravenous fluids
supportive care medications for symptoms monitoring in intensive care |
| gptkbp:bfsParent |
gptkb:Bayer_Aspirin
|
| gptkbp:bfsLayer |
3
|